Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma

Journal of Glaucoma

Volumn 15, Issue 3, 2006, Pages 229-237

  Määttä, Marko ^a,b   Tervahartiala, Taina ^a   Vesti, Eija ^a   Airaksinen, Juhani ^c   Sorsa, Timo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Intraocular pressure; Matrix metalloproteinase; Uveitis; Western blotting; Zymography

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADOLESCENT; ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLAUCOMA SURGERY; HUMAN; MALE; OPEN ANGLE GLAUCOMA; PRIMARY GLAUCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY GLAUCOMA; STATISTICAL SIGNIFICANCE; UVEITIS; WESTERN BLOTTING; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED, 80 AND OVER; AQUEOUS HUMOR; BLOTTING, WESTERN; CHILD; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UVEITIS;

EID: 33745274792     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000212229.57922.72     Document Type: Article

References (48)

1. Moorthy RS, Mermoud A, Baerveldt G, et al. Glaucoma associated with uveitis. Surv Ophthalmol. 1997;41:361-394.
2. Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13:461-465.
3. Herbert HM, Viswanathan A, Jackson H, et al. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004; 13:96-99.
4. Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002; 46:556-562.
5. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that become a prince. Bat Rev Mol Cell Biol. 2002;3:207-214.
6. Fassina G, Ferrari N, Brigati C, et al. Tissue inhibitors of metalloproteinases: regulation and biological activities. Clin Exp Metastasis. 2000;18:111-120.
7. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol. 1996;156:1-4.
8. Kijlstra A. Cytokines: their role in uveal disease. Eye. 1997; 11:200-205.
9. Schönbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998; 161:3340-3346.
10. van den Steen PE, Proost P, Wuyts A, et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. 2000;96:2673-2681.
11. Overall CM, McQuibban GA, Clark-Lewis I. Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem. 2002; 383:1059-1066.
12. Di Girolamo N, Verma MJ, McCluskey PJ, et al. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res. 1996;15:1060-1068.
13. El-Shabrawi YG, Christen WG, Foster SC. Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis. Curr Eye Res. 2000;20:211-214.
14. Wallace GR, Whiston RA, Stanford MR, et al. The matrix metalloproteinase inhibitor BB-1101 prevents experimental autoimmune uveoretinitis (EAU). Clin Exp Immunol. 1999;118:364-370.
15. Cuello C, Wakefield D, Di Girolamo N. Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis. Br J Ophthalmol. 2002;86:290-295.
16. Ueda J, Wentz-Hunter K, Yue BYJT. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci. 2002;43:1068-1076.
17. Schlötzer-Schrehardt U, Lommatzsch J, Kuchle M, et al. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndorome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44:1117-1125.
18. Määttä M, Tervahartiala T, Harju M, et al. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome and exfoliation glaucoma. J Glaucoma. 2005;14:64-69.
19. Sorsa T, Ding Y, Salo T, et al. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases: a functional and Western blot assessment with special reference to their cellular sources in periodontal diseases. Ann NY Acad Sci. 1994;732:112-131.
20. Paju A, Sorsa T, Tervahartiala T, et al. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation. Br J Cancer. 2001;84:1363-1371.
21. Lauhio A, Salo T, Ding Y, et al. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol. 1994;98:21-28.
22. Hanemaaijer R, Sorsa T, Konttinen Y, et al. Matrix metalloproteinase-8 is expressed by rheumatoid synovial fibroblasts and endothelial cells: regulation of tumor necrosis factor-α and doxycycline. J Biol Chem. 1997;272:31504-31509.
23. Sorsa T, Salo T, Koivunen E, et al. Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem. 1997;272:21067-21074.
24. Prikk K, Maisi P, Pirilä E, et al. Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest. 2002;82:1535-1545.
25. Tervahartiala T, Ingman T, Sorsa T, et al. Proteolytic enzymes as indicators of periodontal health in gingival crevicular fluid of patients with Sjögren's syndrome. Eur J Oral Sci. 1995;103:11-16.
26. Owen CA, Hu Z, Lopez-Otin C, et al. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol. 2004;172:7791-7803.
27. Knäuper V, Osthues A, DeClerck YA, et al. Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem J. 1993;291:847-854.
28. Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-10432.
29. Lehti K, Valtanen H, Lohi J, et al. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem. 2000;275:15006-15013.
30. Maisi P, Prikk K, Sepper R, et al. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS. 2002;110:771-782.
31. Tripathi RC, Li J, Chan WFA, et al. Aqueous humor in glaucomatous eyes contains an increased level of TGF-β2. Exp Eye Res. 1994;59:723-728.
32. Rao NA, Wacker WB, Marak GE Jr. Experimental allergic uveitis: clinicopathologic features associated with varying doses of S antigen. Arch Ophthalmol. 1979;97:1954-1958.
33. Mirastschijski U, Haaksma CJ, Tomasek JJ, et al. Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res. 2004;299:465-475.
34. Wahlgren J, Maisi P, Sorsa T, et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol. 2001;194:217-224.
35. Makowski GS, Ramsby ML. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin Chim Acta. 2003;329:77-81.
36. Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659-2665.
37. Bond M, Fabunmi RP, Baker AH, et al. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998;435:29-34.
38. Abraham M, Shapiro S, Lahat N, et al. The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells. Int Immunol. 2002;14:1449-1457.
39. Descamps FJ, Van den Steen PE, Nelissen I, et al. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes. Adv Exp Med Biol. 2003;535:69-77.
40. de Boer JH, Limpens J, Orengo-Nania S, et al. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci. 1994;35:3702-3710.
41. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987;6:1899-1904.
42. Tchetverikov I, Lard LR, DeGroot J, et al. Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis. 2003; 62:1094-1099.
43. El-Shabrawi Y, Walch A, Hermann J, et al. Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uveitis with a selective metalloproteinase-2 and -9 inhibitor. J Neuroimmunol. 2004;155:13-20.
44. Dubois B, Masure S, Hurtenbach U, et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest. 1999; 104:1507-1515.
45. Cataldo DD, Tournoy KG, Vermaelen K, et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol. 2002;161:491-498.
46. Yang YN, Bauer D, Wasmuth S, et al. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and -2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res. 2003;77:227-237.
47. Westerlund U, Ingman T, Lukinmaa PL, et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res. 1996;75:1553-1563.
48. Owen CA, Hu Z, Barrick B, et al. Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol. 2003;29:283-294.